JP2020535436A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535436A5 JP2020535436A5 JP2020518048A JP2020518048A JP2020535436A5 JP 2020535436 A5 JP2020535436 A5 JP 2020535436A5 JP 2020518048 A JP2020518048 A JP 2020518048A JP 2020518048 A JP2020518048 A JP 2020518048A JP 2020535436 A5 JP2020535436 A5 JP 2020535436A5
- Authority
- JP
- Japan
- Prior art keywords
- fgf
- treatment
- subject
- 2sdng
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024064931A JP2024105273A (ja) | 2017-09-29 | 2024-04-12 | Fgf-18化合物に対する反応性を予測する代謝バイオマーカー |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17194220.4 | 2017-09-29 | ||
| EP17194220 | 2017-09-29 | ||
| EP18169324 | 2018-04-25 | ||
| EP18169324.3 | 2018-04-25 | ||
| PCT/EP2018/076395 WO2019063758A1 (en) | 2017-09-29 | 2018-09-28 | METABOLIC BIOMARKERS FOR PREDICTING RESPONSE TO FGF-18 COMPOUND |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064931A Division JP2024105273A (ja) | 2017-09-29 | 2024-04-12 | Fgf-18化合物に対する反応性を予測する代謝バイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020535436A JP2020535436A (ja) | 2020-12-03 |
| JP2020535436A5 true JP2020535436A5 (cg-RX-API-DMAC7.html) | 2021-11-11 |
| JP7791649B2 JP7791649B2 (ja) | 2025-12-24 |
Family
ID=63722380
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020518048A Active JP7791649B2 (ja) | 2017-09-29 | 2018-09-28 | Fgf-18化合物に対する反応性を予測する代謝バイオマーカー |
| JP2024064931A Withdrawn JP2024105273A (ja) | 2017-09-29 | 2024-04-12 | Fgf-18化合物に対する反応性を予測する代謝バイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064931A Withdrawn JP2024105273A (ja) | 2017-09-29 | 2024-04-12 | Fgf-18化合物に対する反応性を予測する代謝バイオマーカー |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11513128B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3687558B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7791649B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111163791A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018343982B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3076029A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3687558T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2918250T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20220760T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE058786T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL273613B2 (cg-RX-API-DMAC7.html) |
| LT (1) | LT3687558T (cg-RX-API-DMAC7.html) |
| PL (1) | PL3687558T3 (cg-RX-API-DMAC7.html) |
| RS (1) | RS63293B1 (cg-RX-API-DMAC7.html) |
| SI (1) | SI3687558T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019063758A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2971315C (en) | 2015-01-29 | 2023-02-14 | Ares Trading S.A. | Immunoassays for high positively charged proteins |
| LT3687558T (lt) | 2017-09-29 | 2022-06-27 | Merck Patent Gmbh | Metaboliniai biožymenys, skirti atsako į fgf-18 junginį numatymui |
| RS63292B1 (sr) | 2017-09-29 | 2022-06-30 | Merck Patent Gmbh | Inflamatorni biomarkeri za predviđanje responsivnosti na jedinjenje fgf-18 |
| IL281333B2 (en) * | 2018-09-10 | 2025-11-01 | Merck Patent Gmbh | A method for reducing risk in a clinical trial |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA75316C2 (uk) | 1996-10-16 | 2006-04-17 | Займодженетікс, Інк. | Гомологи з фактором росту фібробласта |
| EP1551426B1 (en) | 2002-10-07 | 2014-06-25 | ZymoGenetics, Inc. | Methods of administering fgf18 |
| WO2004043237A2 (en) * | 2002-11-08 | 2004-05-27 | Barnes-Jewish Hospital | Uncoupled collagen synthesis and degradation assays |
| DK1828239T3 (da) | 2004-12-10 | 2011-12-19 | Zymogenetics Inc | FGF18-produktion i prokaryote værter |
| US8224579B2 (en) * | 2005-06-17 | 2012-07-17 | The Brigham And Women's Hospital, Inc. | Method of diagnosing osteoarthritis |
| US20070292982A1 (en) | 2006-06-16 | 2007-12-20 | Jeffery Gail Holloway | Method for Manufacturing Transparent Windows in Molded Semiconductor Packages |
| US8207115B2 (en) * | 2006-08-25 | 2012-06-26 | Ares Trading S.A. | Treatment of cartilage disorders with FGF-18 |
| JP2009257842A (ja) * | 2008-04-14 | 2009-11-05 | Ttc:Kk | 変形性関節症の検査方法及び診断用キット |
| US20100098775A1 (en) | 2008-05-02 | 2010-04-22 | Interleukin Genetics, Inc. | Detecting genetic predisposition to osteoarthritis associated conditions |
| US20090299769A1 (en) | 2008-05-29 | 2009-12-03 | Nordic Bioscience Imaging A/S | Prognostic osteoarthritis biomarkers |
| US20120115137A1 (en) | 2010-08-31 | 2012-05-10 | Kornman Kenneth S | Methods of Predicting Osteoarthritis |
| TWI527590B (zh) | 2011-06-17 | 2016-04-01 | 艾瑞斯貿易公司 | Fgf-18之凍乾調配物 |
| EP2880179B1 (en) | 2012-08-06 | 2017-12-13 | Merck Patent GmbH | Genetic markers for predicting responsiveness to fgf-18 compound |
| PL2880181T3 (pl) | 2012-08-06 | 2019-03-29 | Merck Patent Gmbh | Biomarkery prognostyczne w zaburzeniach chrząstki |
| US9829493B2 (en) * | 2013-07-15 | 2017-11-28 | Steven J. Svoboda | Methods and apparatus for assessment of risk for joint injury |
| TW201536320A (zh) | 2013-12-02 | 2015-10-01 | Abbvie Inc | 治療骨性關節炎之組合物及方法 |
| KR102434024B1 (ko) | 2013-12-24 | 2022-08-22 | 아레스 트레이딩 에스.아. | 알지네이트/콜라겐 히드로겔 중의 fgf-18 제형물 |
| NZ721332A (en) | 2013-12-24 | 2022-07-01 | Ares Trading Sa | Fgf-18 formulation in xyloglucan gels |
| ES2698117T3 (es) | 2014-02-20 | 2019-01-31 | Merck Patent Gmbh | Implante que comprende FGF-18 |
| KR102437057B1 (ko) | 2014-02-20 | 2022-08-26 | 메르크 파텐트 게엠베하 | 이식편 이식 및 조직 공학 절차에 있어서의 fgf-18 |
| HRP20181570T1 (hr) | 2014-02-20 | 2018-11-30 | Merck Patent Gmbh | Režim doziranja spoja fgf-18 |
| CA2971315C (en) | 2015-01-29 | 2023-02-14 | Ares Trading S.A. | Immunoassays for high positively charged proteins |
| WO2017079759A1 (en) | 2015-11-06 | 2017-05-11 | Samumed, Llc | 2-(1h-indazol-3-yl)-3h-imidazo[4,5-c]pyridines and their anti-inflammatory uses thereof |
| US9983214B2 (en) | 2016-04-15 | 2018-05-29 | Esm Technologies, Llc | Method for evaluating articular joint therapeutics |
| RS63292B1 (sr) | 2017-09-29 | 2022-06-30 | Merck Patent Gmbh | Inflamatorni biomarkeri za predviđanje responsivnosti na jedinjenje fgf-18 |
| LT3687558T (lt) * | 2017-09-29 | 2022-06-27 | Merck Patent Gmbh | Metaboliniai biožymenys, skirti atsako į fgf-18 junginį numatymui |
| IL281333B2 (en) | 2018-09-10 | 2025-11-01 | Merck Patent Gmbh | A method for reducing risk in a clinical trial |
-
2018
- 2018-09-28 LT LTEPPCT/EP2018/076395T patent/LT3687558T/lt unknown
- 2018-09-28 SI SI201830686T patent/SI3687558T1/sl unknown
- 2018-09-28 CN CN201880063185.7A patent/CN111163791A/zh active Pending
- 2018-09-28 HR HRP20220760TT patent/HRP20220760T1/hr unknown
- 2018-09-28 HU HUE18782014A patent/HUE058786T2/hu unknown
- 2018-09-28 WO PCT/EP2018/076395 patent/WO2019063758A1/en not_active Ceased
- 2018-09-28 IL IL273613A patent/IL273613B2/en unknown
- 2018-09-28 ES ES18782014T patent/ES2918250T3/es active Active
- 2018-09-28 PL PL18782014.7T patent/PL3687558T3/pl unknown
- 2018-09-28 RS RS20220558A patent/RS63293B1/sr unknown
- 2018-09-28 EP EP18782014.7A patent/EP3687558B1/en active Active
- 2018-09-28 JP JP2020518048A patent/JP7791649B2/ja active Active
- 2018-09-28 US US16/650,881 patent/US11513128B2/en active Active
- 2018-09-28 DK DK18782014.7T patent/DK3687558T3/da active
- 2018-09-28 CA CA3076029A patent/CA3076029A1/en active Pending
- 2018-09-28 AU AU2018343982A patent/AU2018343982B2/en active Active
-
2022
- 2022-09-07 US US17/930,389 patent/US12332251B2/en active Active
-
2024
- 2024-04-12 JP JP2024064931A patent/JP2024105273A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Martinez | Treatment of acute portal vein thrombosis by non-traditional anticoagulation | |
| JP2013507968A5 (cg-RX-API-DMAC7.html) | ||
| Broz et al. | Neuropilin (NRPs) related pathological conditions and their modulators | |
| JP2020535423A5 (cg-RX-API-DMAC7.html) | ||
| RU2015144699A (ru) | Адреномедуллин для направленной терапии по снижению кровяного давления | |
| JP2015508063A5 (cg-RX-API-DMAC7.html) | ||
| Niehues et al. | Mutations of the gene FNIP1 associated with a syndromic autosomal recessive immunodeficiency with cardiomyopathy and pre‐excitation syndrome. | |
| CN107075473A (zh) | 其中未分化细胞被去除的分化诱导的细胞群、其用途及其制备方法 | |
| HRP20191145T1 (hr) | Postupak predviđanja ishoda liječenja s afliberceptom kod pacijenta za kojeg se sumnja da ima rak | |
| CN108697729A (zh) | 新型GLUT抑制剂rapaglutin及其用途 | |
| JP2010500006A5 (cg-RX-API-DMAC7.html) | ||
| CA2819080A1 (en) | Agtr1 as a marker for bevacizumab combination therapies | |
| Ebrahimi et al. | Dengue fever in Iran: A case report | |
| CN105801700A (zh) | 抗单核细胞白血病相关抗原MLAA-34全人源单克隆单链抗体ScFv | |
| CN105745219A (zh) | 结合β淀粉状蛋白的肽及其用于治疗和诊断阿尔茨海默痴呆症的用途 | |
| RU2014123166A (ru) | Восприимчивость к ингибиторам ангиогенеза | |
| JP2009538935A5 (cg-RX-API-DMAC7.html) | ||
| Pérez-Martínez et al. | Magnetic resonance imaging and immunohistochemistry of primary vertebral hemangiosarcoma in a dog and implications for diagnosis and therapy | |
| RU2014110271A (ru) | Восприимчивость к ингибиторам ангиогенеза | |
| ES2857513T3 (es) | Oligonucleótidos y su uso | |
| Smaili et al. | CALR gene mutational profile in myeloproliferative neoplasms with non-mutated JAK2 in Moroccan patients: A case series and germline in-frame deletion | |
| CN107987147A (zh) | 一种mg53多聚体制备方法及其用途 | |
| JP2018500879A5 (cg-RX-API-DMAC7.html) | ||
| Murk et al. | Persistent spiking fever in a child with acute myeloid leukemia and disseminated infection with enterovirus | |
| A. Saad Zaghloul et al. | Functional evaluation of imatinib mesylate in hepatocellular carcinoma cells |